Showing results 33 to 52 of 55
< previous
next >
Issue Date | Title | Sub-Title | Author(s) | Journal Name | Volume Number | Issue Number | Pages |
2011 | Learning by exporting: The contingent role of capabilities | - | Chatterjee, Chirantan ; Nandkumar, Anand ; Dhanaraj, Charles | | | | |
2015 | Life sciences symposium | - | Chatterjee, Chirantan | | | | |
2016 | Maximizing local value addition in Indian mobile phone manufacturing: a practical phased approach | - | Pathak, Tarun ; Chatterjee, Chirantan ; Shah, Neil | | | | 62p. |
2017 | Mitigating regulatory impact : the case of partial price controls on metformin in India | - | Bhaskarabhatla, Ajay ; Chatterjee, Chirantan ; Anurag, Priyatam ; Pennings, Enrico | Health Policy And Planning | Vol.32 | Iss.2 | 194-204p. |
2014 | Panel invitee, globalizing innovation: The current Discourse | - | Chatterjee, Chirantan | | | | |
2015 | Patents and technology standards: The data sets | - | Chatterjee, Chirantan | | | | |
6-Mar-2015 | Physicians/doctors and their role in cartels and irrational bundling of combination drugs in Indian pharmaceutical industry | - | Chatterjee, Chirantan | | | | |
2014 | Regional differences in first mover advantages | - | Chatterjee, Chirantan | | | | |
2011 | Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry | - | Branstetter, Lee G ; Chatterjee, Chirantan ; Higgins, Matthew J | | | | 41p. |
2016 | Regulation and welfare: Evidence from paragraph IV generic entry in the pharmaceutical industry | - | Branstetter, Lee ; Chatterjee, Chirantan ; Higgins, Matthew J | Rand Journal of Economics | Vol.47 | Iss.4 | 857-890p. |
1-Apr-2013 | Regulation, competition, and innovation in the global bio-pharmaceutical industry? | - | Chatterjee, Chirantan | | | | |
2014 | Retail union and regional first mover advantages | - | Bhaskarabhatla, Ajay ; Chatterjee, Chirantan ; Karreman, Bas | | | | |
2016 | Starving (or Fattening) the Golden Goose?: Generic entry and the incentives for early stage pharmaceutical innovation | - | Branstetter, Lee ; Chatterjee, Chirantan ; Higgins, Matthew John | | | | |
2015 | Starving (or Fattening) the Golden Goose?: Generic entry and the incentives for early-stage pharmaceutical innovation | - | Branstetter, Lee ; Chatterjee, Chirantan ; Higgins, Matthew John | | | | 47p. |
2016 | Starving (or fattening) the golden goose?: Generic entry and the incentives for early-stage pharmaceutical innovation | - | Chatterjee, Chirantan ; Branstetter, Lee ; Higgins, Eric | | | | |
2016 | Starving (or fattening) the golden goose?: Generic entry and the incentives for early-stage pharmaceutical innovation | - | Chatterjee, Chirantan ; Branstetter, Lee ; Higgins, Eric | | | | |
16-Dec-2016 | State-championed or private low-end disruption! Who will win this horse race in steady state? | - | Chatterjee, Chirantan | The Economic Times | | | |
6-Jan-2012 | Supplier behavior and product quality in Indian pharmaceutical markets: Implications for price regulation and patent enforcement from pharmaceutical demand in India | - | Chatterjee, Chirantan ; Kubo, Kensuke ; Pingali, Viswanath | | | | |
2016 | The consumer welfare implications of governmental policies and firm strategy in markets for medicines | - | Chatterjee, Chirantan | | | | |
2015 | The consumer welfare implications of governmental policies and firm strategy in markets for medicines | - | Chatterjee, Chirantan ; Kubo, Kensuke ; Pingali, Viswanath | Journal of Health Economics | Vol.44 | | 255-273p. |